Matrilin-2, a Large, Oligomeric Matrix Protein, Is Expressed by a Great Variety of Cells and Forms Fibrillar Networks*

Dorothea PiechaDagger , Selen Muratoglu§, Matthias Mörgelin, Nik HauserDagger , Daniel Studerparallel , Ibolya Kiss§, Mats PaulssonDagger , and Ferenc Deák§**

From the Dagger  Institute for Biochemistry, Medical Faculty, University of Cologne, D-50931 Cologne, Germany, the § Institute of Biochemistry, Biological Research Center of the Hungarian Academy of Sciences, H-6701 Szeged, Hungary, the  Department of Cell and Molecular Biology, Lund University, S-22100 Lund, Sweden, and the parallel  M. E. Müller-Institute for Biomechanics, CH-3010 Bern, Switzerland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Matrilin-2 is a member of the protein superfamily with von Willebrand factor type A-like modules. Mouse matrilin-2 cDNA fragments were expressed in 293-EBNA cells, and the protein was purified, characterized, and used to immunize rabbits. The affinity-purified antiserum detects matrilin-2 in dense and loose connective tissue structures, subepithelial connective tissue of the skin and digestive tract, specialized cartilages, and blood vessel walls. In situ hybridization of 35S-labeled riboprobes localizes the matrilin-2 mRNA to fibroblasts of dermis, tendon, ligaments, perichondrium, and periosteum; connective tissue elements in the heart; smooth muscle cells; and epithelia and loose connective tissue cells of the alimentary canal and respiratory tract. RNA blot hybridization and immunoblotting revealed both matrilin-2 mRNA and protein in cultures of a variety of cell types, confirming the tissue distribution. Alternative splicing affects a module unique for matrilin-2 in all of the above RNA sources. SDS-polyacrylamide gel electrophoresis and electron microscopy reveals matrilin-2 from tissue extracts and cell line cultures as a mixture of mono-, di-, tri-, and tetramers. Matrilin-2 is substituted with N-linked oligosaccharides but not with glycosaminoglycans. Because of other, yet unidentified, cell-type dependent posttranslational modifications, the monomer is heterogeneous in size. Immunofluorescence showed that matrilin-2 functions by forming an extracellular, filamentous network.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Extracellular matrix provides physical support to the cells, delineates pathways for cell migration during differentiation and tissue regeneration, and provides the necessary milieu for the normal cell metabolism and development. Collagen fibers and proteoglycan aggregates provide the structural basis for matrix architecture. Noncollagenous proteins modulate the organization of these elements, form collagen-associated or independent networks, and are parts of cell migratory pathways.

The matrix molecules share homologous modules, protein domains of common evolutionary origin, but a great functional variability of the homologous modules in different proteins has been observed. The recently discovered matrilins (for a review, see Ref. 1) are typical modular proteins belonging to the superfamily with von Willebrand factor type A-like (vWFA)1 modules. Members of the matrilin family are found in a wide variety of extracellular matrices. Matrilin-1, formerly called cartilage matrix protein, and matrilin-3 (2, 3) are abundant in cartilage, while matrilin-2 (4) and matrilin-4 (5) show a broader tissue distribution. Thus, all forms of connective tissue appear to contain at least one form of matrilin, indicating a general and important function for this protein family.

Matrilin-2 was found to contain the same protein modules in the same order as matrilin-1 (4). The precursor protein in mouse is 956 amino acids long and consists of a putative signal peptide, two vWFA domains connected by 10 epidermal growth factor-like modules, a potential oligomerization domain, and a unique segment. The ability of the 38 C-terminal amino acid moieties to form an alpha -helical coiled-coil was shown by Pan and Beck (6). Matrilin-2 mRNA was detected by filter hybridization in a variety of mouse organs including calvaria, uterus, heart, and brain as well as fibroblast and osteoblast cell lines. A group of 120-150-kDa bands was, after reduction, recognized specifically with an antiserum against the matrilin-2-glutathione S-transferase fusion protein in media of the matrilin-2-expressing cell lines. Immunolocalization of matrilin-2 in developing skeletal elements showed reactivity in the perichondrium and the osteoblast layer of trabecular bone.

In order to gain a better understanding of the potential function of matrilin-2, we have determined the spatial expression of the gene by radioactive in situ hybridization. A new antiserum with a higher titer to the native matrilin-2 was raised using, as an antigen, matrilin-2 expressed in a eukaryotic cell line, and the protein was immunolocalized in mouse tissues. Furthermore, matrilin-2 was purified from media of cells overexpressing the full-length protein and visualized by electron microscopy to provide information on the molecular dimensions and oligomeric structure of the protein. The structural information was extended by SDS-PAGE analysis of the intact protein and the reduced subunits. Posttranslational modification of the protein and alternative splicing of the mRNA were also characterized. Finally, formation of an extracellular network in cultures of cells expressing matrilin-2 was demonstrated by indirect immunofluorescence. The potential function and suggested molecular architecture of the protein is discussed.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Mouse Strains and Cell Cultures

BALB/c or NMRI mouse strains were used for RNA or protein analysis, respectively. The mouse fibroblastic cell lines WEHI 164 and NIH 3T3, the rat osteogenic sarcoma UMR-106, and the small intestine epithelial IEC-6 cell lines were obtained from the American Type Culture Collection (Rockville, MD). The mouse C2/7 cells with skeletal muscle characteristics (7), the smooth muscle-like cell 9E11G (8), the keratinocyte carcinoma PVD(A)I (9), the rat Schwann cell line RN22 (10), and the Swarm rat chondrosarcoma cell line (RCSC) (11) were obtained from the laboratories of origin. The mouse immortalized endothelial cells m1END, derived from mesenteric lymph nodes (12), and the SV40-transformed lymphoid vascular endothelial cell SVEC (13) were provided by L. Sorokin and R. Hallmann (Erlangen); smooth muscle cells (SMC) from rat aorta were cultured by F. Michaelsen (Cologne), using standard methods (14). Unless recommended otherwise by the supplier, the cell lines were cultivated in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Life Technologies, Inc.), and utilized for RNA and protein analyses.

RNA Preparation and Analysis

Total RNA was prepared from guanidinium thiocyanate extracts of various cell lines using the RNA isolation kit of Stratagene. For RNA blot analysis, 7-µg aliquots were electrophoresed, blotted to Hybond N filter (Amersham Pharmacia Biotech) and hybridized consecutively with pCRP12 cDNA (4) and chicken 27 S rRNA gene fragment. For the study of RNA alternative splicing, total RNA was reverse transcribed with Moloney murine leukemia virus reverse transcriptase (Life Technologies) using oligo(dT) primer. Nested polymerase chain reactions were performed using first the distal primers 5'-GGACGGGCTCAGGATGA-3' and 5'-CTGTATCTCAGGCGATTTTC-3' and then the proximal primer pair 5'-CATTGACAAGCATCTCTTCT-3' and 5'-TTTGTGTAGACCGTGAAAGA-3' flanking the unique region of mouse matrilin-2.

In Situ Hybridization

Preparation of Tissue Sections-- For paraffin embedding, tissue specimens were fixed overnight in 95% ethanol, 1% acetic acid; dehydrated in ethanol; cleared in xylol; and embedded in low melting point paraffin (Paraplast, Sigma). Sections of 7-9 µm were cut and mounted on poly-L-lysine-coated slides. For cryostat sections, specimens were fixed overnight in 4% paraformaldehyde, 8 mM NaHPO4, 0.15 M NaCl, pH 7.4; decalcified, if necessary, in 15% EDTA, 2% paraformaldehyde, 4 mM NaHPO4, pH 7.4; and embedded in Tissue-Tek O.C.T. compound (Sakura Finetek Europe). 12-µm sections were cut.

Hybridization-- For pretreatment, in situ hybridization, and washing, the protocol as outlined by Hofstetter et al. (15) was used. Briefly, sections were deparaffinized and rehydrated, if necessary, and then digested with proteinase K (1 µg/ml), postfixed, and acetylated in 0.25% acetic anhydride. Riboprobes were labeled with [35S]CTP and hydrolyzed to 150-nucleotide average length. The sections were hybridized for 12-16 h at 53 °C with riboprobes at a final activity of 1-4 × 107 cpm/ml, depending on their length. After hybridization, the tissue sections were washed at 53 °C in 50% formamide, 2 × SSC, 1 mM EDTA, 10 mM dithiothreitol; treated with RNase T1 (1 unit/ml); and washed again at 53 °C in 50% formamide, 0.2× SSC, 1 mM EDTA. The slides were dehydrated and dipped in LM1 photoemulsion (Amersham Pharmacia Biotech). Autoradiography was performed for 5-10 days, and sections were counterstained in Mayer's hematoxylin (Merck).

Expression and Purification of Recombinant Matrilin-2

Partially overlapping cDNA fragments in the mouse matrilin-2 clones pCRP207, pCRP190, and pCRP12 (4) were combined to full-length cDNA using suitable restriction enzymes. One AflII site was inserted immediately upstream of the first AUG codon by polymerase chain reaction. After digestion with AflII and NotI, a 3.3-kilobase pair cDNA fragment was inserted into the expression vector pCEP-Pu (16), cleaved previously with AflII and NotI. The resulting clone, pCEP-Mtr2, encoded the full-length matrilin-2 precursor, including the secretion signal peptide.

The recombinant plasmid was introduced into the human embryonic kidney cell line 293-EBNA (Invitrogen), which constitutively expresses the EBNA-1 gene product from Epstein-Barr virus. The transfected cells were selected with 1 µg/ml puromycin and grown to confluency. Secretion of matrilin-2 into the culture medium was verified by SDS-PAGE and immunoblotting, using antiserum against a matrilin-2-glutathione S-transferase fusion peptide (4). Serum-free culture medium was dialyzed against 2 M urea, 50 mM Tris-HCl, pH 8.6, and applied to a DEAE-Sepharose-FF column. The bound proteins were eluted with a linear gradient of 0.05-0.4 M NaCl. Fractions eluted between 0.1 and 0.2 M NaCl were pooled, and matrilin-2 was further purified by gel filtration through a Sepharose CL-4B column equilibrated in 2 M urea, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4. The final purification was achieved on a Heparin-Sepharose column equilibrated in the same buffer. Matrilin-2 bound exclusively to heparin and was eluted at about 0.3 M NaCl.

Another cDNA fragment encoding the 10 EGF-like modules and the vWFA2 module of mouse matrilin-2 was inserted into the NheI-NotI sites of the pCEP-Pu vector, downstream of the secretion signal sequence of BM40 (16). The cells were transfected, and the selection and collection of media followed as mentioned above. The serum-free medium was diluted 3-fold with 50 mM Tris-HCl, pH 7.4, and applied to a Q-Sepharose-FF column. The bound proteins were eluted with a linear gradient of 0.05-0.4 M NaCl. Fractions containing the matrilin-2 fragment were refractionated on a Mono-Q fast protein liquid chromatography column and were apparently free of contaminants. The purified matrilin-2 fragment was used to immunize rabbits. The antiserum was purified by affinity adsorption to the antigen.

Immunoblotting of Cell Culture Media and Mouse Organ Extracts

Cell cultures were grown to confluency in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. The cell layers were washed and cultured for 48 h without serum, and the medium was harvested. Several mouse organs were homogenized using a Polytron homogenizer and extracted with 0.25 M NaCl, 50 mM Tris-HCl, pH 7.4, containing as protease inhibitors 10 mM EDTA, 2 mM N-ethylmaleimide, 2 mM phenylmethylsulfonyl fluoride. After centrifugation, aliquots of the supernatant were analyzed. For immunoblotting, samples were submitted to SDS-polyacrylamide gel electrophoresis according to the protocol of Laemmli (17), using gradient gels of 4-15% polyacrylamide. Proteins were transferred electrophoretically to a nitrocellulose filter and developed with affinity-purified antiserum to matrilin-2, followed by peroxidase-conjugated swine anti-rabbit IgG (DAKO) and the ECL chemiluminescence procedure (Amersham Pharmacia Biotech) as suggested by the suppliers.

Immunohistochemistry and Immunofluorescence of Cell Layers

Immunohistochemistry was performed as described previously (18), using the affinity-purified anti-matrilin-2 antiserum together with a swine anti-rabbit IgG-peroxidase complex and 3-amino-9-ethylcarbazole as substrate on unfixed cryosections from adult and newborn mouse. For immunofluorescence of cell cultures, cells were plated onto plastic chamber slides, and after reaching confluency they were fixed in 2% paraformaldehyde in phosphate-buffered saline for 10 min. In some experiments, cells were permeabilized by treatment with 10% Nonidet P-40 in phosphate-buffered saline for 10 min. Nonspecific antibody binding was blocked by incubation with 1% (w/v) bovine serum albumin in phosphate-buffered saline for 1 h. The cells were treated with the affinity-purified antibody to matrilin-2 for 1 h followed by CyTM3-conjugated affinity-pure goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories). Pictures were taken with a Zeiss Axiophot microscope equipped with a fluorescence source.

Analysis of Posttranslational Modifications

The potential substitution with sulfated glycosaminoglycans was determined by metabolic labeling. 293-EBNA cells transfected with pCEP-Mtr2 were grown in serum- and sulfate-free minimal essential medium containing 50 µCi/ml [35S]sulfate (Amersham Pharmacia Biotech). After a 48-h labeling period, media were harvested and precipitated with trichloroacetic acid (final concentration 12%). The radiolabeled proteins were separated by SDS-PAGE, and radioactive bands were visualized by fluorography after treatment with 1 M sodium salicylate.

Chondroitinase ABC and Heparitinase Digestions-- Cell culture media from 293-EBNA cells transfected with pCEP-Mtr2 were incubated with 0.7 milliunits/µl heparitinase I (Sigma; from Flavobacterium heparinum) and 1.7 milliunits/µl chondroitinase ABC (Sigma) for 7 h at 37 °C. Aliquots of the digested and control media were analyzed after SDS-PAGE and immunoblotting with specific antiserum to matrilin-2.

To test for the presence of N-glycosidically linked oligosaccharides, 293-EBNA cells transfected with pCEP-Mtr2 were grown in serum-free Dulbecco's modified Eagle's medium for 48 h in the presence of tunicamycin (Sigma) at 0.5 mg/ml. Media from tunicamycin-treated and control cells were analyzed after SDS-PAGE and immunoblotting with specific antiserum to matrilin-2. Parallel blots were developed with antibodies to nidogen, which is endogenously produced by the 293-EBNA cells and served as a positive control of better known glycosylation (not shown).

N-Glycosidase F Digestion-- Purified matrilin-2 in incubation buffer containing 50 mM Tris-HCl, pH 7.4, 50 mM sodium chloride, 0.5% Nonidet P-40, and 0.1% SDS was denatured by heating at 100 °C for 2 min. After denaturation, the protein was incubated with 0.3 units of N-glycosidase F (Roche Molecular Biochemicals) per mg of protein for 20 h at 37 °C. The control sample was treated similarly without adding N-glycosidase F. The digested and control samples were analyzed by 4-15% SDS-PAGE and stained with silver nitrate.

Electron Microscopy

Purified matrilin-2 (10 µg/ml) was adsorbed to a 400-mesh carbon-coated copper grid, which was rendered hydrophilic by glow discharge at low pressure in air. The grid was immediately blotted, washed with two drops of water, and stained with 0.75% uranyl formate for 15 s. Samples were observed in a Jeol 1200 EX transmission electron microscope operated at 60-kV accelerating voltage and × 75,000 magnification. Images were recorded on Kodak ESTAR Thick Base 4489 plates without preirradiation at a dose of typically 2000 electrons/nm2. Evaluation of the data from electron micrographs was done as described previously (19).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Matrilin-2 Is Deposited in All Forms of Connective Tissue, Some Types of Smooth Muscle, and a Few Epithelia-- A cDNA fragment encoding the EGF-like modules and the second vWFA domain of mouse matrilin-2 was inserted into the pCEP-Pu vector, utilizing the secretion signal sequence of BM40 (16). The recombinant plasmid was introduced into the 293-EBNA cell line, where it was stably maintained in episomal form. The matrilin-2 fragment, secreted into the tissue culture medium, was purified and used to immunize rabbits. The antiserum, after affinity purification, specifically reacts with matrilin-2 and does not show any cross-reactivity (see Fig. 5A).

Matrilin-2 was localized immunohistochemically in cryostat sections of adult and newborn mice (Fig. 1). The protein is most abundant in dense connective tissue, including tendon, ligaments, perichondrium, periosteum, dura mater, epineurium (Fig. 1, G-I); perimysium of skeletal, heart, and smooth muscle (Fig. 1, B, C, E, and G); submucosa of alimentary canal (Fig. 1, E and F); the reticular layer of dermis (Fig. 1, A and G); spleen capsule; and the annulus fibrosus, chordae tendineae, and valves of heart (not shown). In loose connective tissue, local concentration of the protein is not as high. It is most abundant in the papillary layer of dermis (Fig. 1A) and spleen trabeculae (not shown). It is less abundant, but detectable, in the lamina propria of alimentary canal and the tunica adventitia of blood vessels and respiratory tract (not shown in detail). Matrilin-2 is also detectable to variable extents in specialized connective tissue, including the zones of proliferation and hypertrophy in epiphyseal cartilage (Fig. 1G), elastic cartilage of the ear (not shown), fibrocartilage in the annulus fibrosus of the intervertebral disc (Fig. 1, H-I), and bone, where it lines the marrow cavities. The protein was abundant in the myometrium (not shown) and was also detectable between muscularis mucosae and muscularis externa of the alimentary canal, possibly associated with the nervous plexus (Fig. 1E). The amount of the protein was above the detectability threshold in a few specialized epithelia, e.g. the sublingual gland in the newborn head and the lens epithelium or underlying basement membrane of day 16.5 embryos (not shown). In nervous tissue, matrilin-2 was observed in the dura and pia mater of brain and spinal cord as well as the perineurium of peripheral nerves (Fig. 1H).


View larger version (139K):
[in this window]
[in a new window]
 
Fig. 1.   Immunohistochemistry of mouse tissue. Sections from newborn (A, F, G, H, I, and J) and adult (B-E) animals were made, and matrilin-2 (A-I) or matrilin-1 (J) was detected with affinity-purified antisera. A, in skin from the leg, strong immunostaining was observed in the papillary layer (pl), and somewhat weaker staining was seen in the reticular layer (rl) of dermis and at the base of hair papillae (hp). ep, epidermis. B, in the heart, the auricle (au) is stained more intensely than the atrium wall (aw). C, in the ventricles, the connective tissue surrounding some capillaries (ca) are positive, and staining of the basement membrane around myoblasts is weak. The interstitial connective tissue (ct) is strongly reactive. D, in kidney, the arcuate arteries (aa) show strong staining. E, the esophagus epithelium (ep) is not stained, but the underlying basement membrane and mucosa show strong immunoreaction. In the muscularis externa, connective tissue (ct) between the circular and longitudinal smooth muscle cell layers shows strong immunostaining, possibly associated with the nervous plexus. F, in the oral cavity of a newborn mouse, fibers of periodontal membrane around the developing incisor (i) show strong staining as well as the submucosa of hard and soft palate and the lamina propria of the tongue (to). There is no staining in the epithelial layers (ep). G, in the ossifying skeleton of the leg, the perichondrium (pc), periosteum (po), meniscus, synovial capsule, and ligaments (li) are the most strongly positive areas. Moderate immunostaining of the cartilage matrix (c) is enhanced in the lacunae of hypertrophic chondrocytes (hc). Strong immunoreaction of the developing tendon (te) and staining in the dermis and perimysium can also be observed in the leg. H, in a cross-section of the vertebral column, in addition to the perichondrium (pc), periosteum, and ligaments, note the signal in the dura mater spinalis (dm) and the intense labeling of the epi- and perineurium covering the dorsal (dr) and ventral root fibers as well as the spinal nerve. vb, vertebral body. I, in longitudinal sections of the vertebral column, the annulus fibrosus of the intervertebral discs (ivd) gave the strongest signal for matrilin-2. Tendon (te), ligaments (li), and dermis are also immunoreactive. vb, vertebral body. J, in parallel sections, matrilin-1 was detected in the vertebral bodies (vb), both in the epiphysis and the calcified metaphysis. Bar, 0.05 mm (A and C), 0.1 mm (B), 0.2 mm (E and H), 0.266 mm (D), and 0.4 mm (F, G, I, and J).

The Matrilin-2 Gene Is Transcribed in Fibroblasts, Osteoblasts, Smooth Muscle Cells, and Some Epithelial Cells-- In order to reveal where the matrilin-2 mRNA is produced, eventually leading to extracellular deposition of the protein, we performed in situ hybridization. Three antisense riboprobes, complementary to nonoverlapping regions of the matrilin-2 mRNA were hybridized to cryostat and paraffin sections of 5-10-week-old mouse. The hybridization of the radioactive riboprobe was detected by autoradiography and the silver grains were visualized in dark field. Bright field photomicrographs of the same fields helped to identify the hybridizing tissues in the sections (Fig. 2). Parallel sections were hybridized with sense riboprobes and verified the specificity of hybridization (not shown).


View larger version (151K):
[in this window]
[in a new window]
 
Fig. 2.   In situ hybridization of matrilin-2 cRNA to sections of adult mouse organs. Antisense riboprobes were hybridized to cryostat sections (A-D) or paraffin sections (E-H) of 5-week-old mice. A-H, light field micrographs, A'-H' are corresponding dark field micrographs. In a longitudinal section of the tail (A and B), mRNA is detected in dermis fibroblasts, at the base of hair follicle, and in tendon (te) cells. A, the stratified, keratinized epithelium reflects the light, but is not truly positive. B, the gene is also expressed in the vertebral body in the perichondrium (pc), ligaments (li), and epiphyseal cartilage, especially the zone of early hypertrophy (hc) and in cells lining the bone marrow (bm) cavities. C, the cross-section of uterus shows an overall strong hybridization signal. Note the accumulation of grains in the perimetrium (pm), mesentery (me), and blood vessels (bv). D, in the heart, the hybridization signal increases from the ventricles toward the atria and is the strongest in the atrioventricular valves (av), the chorda tendinea (ct), and the auricle (not shown). pm, papillary muscle. E, in the oblique section of trachea (tr) and esophagus (es), the esophageal epithelium, the ciliated tracheal epithelium, and seromucous glands (gl) in the submucosa and adventitia give a strong hybridization signal. c, cartilage. F, in a larger magnification, the cartilage ring (c) is weakly positive, in comparison with the signal in the seromucous glands (gl). G, in the esophagus, the epithelium is more strongly labeled than the subepithelial connective tissue. H, in colon, the mucosa (mu), submucosa, and serosa show a strong signal. me, muscularis externa. Scale bar, 0.1 mm (A, B, and F-H), 0.2 mm (C and D), or 0.4 mm (E).

The results of in situ hybridization confirmed and extended the data obtained by immunohistochemistry. Connective tissue cells are clearly positive in dense and loose as well as specialized connective tissue. Dense connective tissue fibroblasts show characteristic accumulation of grains in tendon, ligaments, perichondrium, periosteum (Fig. 2, A and B); cells in the reticular layer of dermis and at the base of hair papillae (Fig. 2A); and annulus fibrosus of heart, atrioventricular valve, and chordae tendineae (Fig. 2D). Loose connective tissue cells also gave hybridization signals in the adventitia of trachea (Fig. 2, E and G) and the mesentery cells (Fig. 2C). Matrilin-2 gene expression was observed in epiphyseal cartilage, in the zones of proliferation and early hypertrophy (Fig. 2B), as well as in osteoblasts of the calvaria (not shown).

Muscle cells showed a detectable level of gene expression, albeit not as high as that in fibroblasts. A strong in situ hybridization signal was observed in the organs where previous Northern hybridization (4) showed a high steady state level of matrilin-2 mRNA. The uterus gave an overall strong hybridization signal (Fig. 2C). Heart was also strongly positive, but with a gradient toward the regions richer in connective tissue cells, e.g. the atria, auricle, valves, and chordae tendineae (Fig. 2D).

In addition to connective tissue cells and myoblasts, some epithelia also showed clearly positive hybridization signals. In paraffin sections, the secretory epithelium of esophagus, the mucosa, and serosa of colon as well as the seromucous glands of trachea showed strong hybridization (Fig. 2, E-H).

Relative Abundance of Matrilin-2 mRNA in Established Cell Lines-- In some cases it was difficult to determine with certainty the cell types where the gene expression was observed by in situ hybridization. For example, smooth muscle cells are in close association with fibroblasts, and epithelial cells form thin layers in close proximity to the underlying connective tissue. Therefore, we examined matrilin-2 mRNA and protein production in homogeneous cultures of permanent cell lines.

Total RNA samples were isolated from cultured cells, and the relative amount of matrilin-2 mRNA was estimated by Northern hybridization (Fig. 3). In all of the cell lines examined, expression of the gene was observed. We previously demonstrated that the fibroblastic cell lines L929, WEHI 164, NIH 3T3, and the rat osteogenic sarcoma UMR-106 expressed the gene (4). In the present experiment, the mRNA level in NIH 3T3 cells (Fig. 3, lane 1) was compared with other cell lines. In two samples, isolated from the rat chondrosarcoma cell line and the 9E11G smooth muscle-like cells, the matrilin-2 mRNA level was higher than in NIH3T3 cells. The other smooth muscle cell line, SMC, isolated from rat aorta, and the differentiated skeletal muscle myotube C2/7 contained less, but significant, amounts of matrilin-2 mRNA, confirming that the gene can be expressed in cells with myoblast characteristics. The intestinal epithelial cell line IEC6 and the Schwannoma cell line RN22 also expressed the gene at a detectable level. The least amount of matrilin-2 mRNA was found in the keratinocyte carcinoma PVD(A)I. In a separate experiment, matrilin-2 mRNA was detected in the SVEC endothelial cell line (not shown). In summary, not only the connective tissue cell types contained matrilin-2 mRNA, but gene expression was also observed in myoblasts and in the epithelial and endothelial cell lines tested.


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 3.   Filter hybridization of cell culture RNA samples. The RNA samples were isolated from the cell lines indicated at the top. The filter was hybridized consecutively with matrilin-2 cDNA (MTR2) and a chicken rDNA fragment (28S). For a description of the cell lines, see "Materials and Methods."

Previous analysis indicated that the sequence variability within the unique region may be a consequence of alternative splicing. Therefore, we performed reverse transcription-polymerase chain reaction analysis to determine if there is further mRNA heterogeneity within the translated region. In the SVEC endothelial and the rat chondrosarcoma cell lines, alternative splicing affected only the middle third of the unique module but not the region encoding the coiled coil, the vWFA2, or EGF-like modules (data not shown). Systematic comparison of the RNA samples showed that a 57-nucleotide-long region is alternatively retained or spliced out in all of the 10 cell lines studied (Fig. 4).


View larger version (89K):
[in this window]
[in a new window]
 
Fig. 4.   Analysis of mouse matrilin-2 mRNA heterogeneity within the unique region by reverse transcription-polymerase chain reaction. The analysis was performed as described under "Materials and Methods." Template RNA was isolated from rat chondrosarcoma tissue (RCS) or the mouse and rat cell lines indicated at the top. C, amplification of the longer segment using pCRP12 cDNA clone (4) as template. M, pUC12 HaeIII DNA ladder. On the left, sizes of the two alternative splice products are indicated. At high concentrations, the two specific polymerase chain reaction products formed heteroduplexes of lower electrophoretic mobility (hd).

The Matrilin-2-specific Antiserum Reacts with Multiple Protein Bands upon Electrophoresis of Unreduced Samples-- In order to gain information about the relative amount and presumed oligomeric structure of matrilin-2, culture media from cell lines and extracts from tissues were compared by SDS-PAGE and, in part, immunoblotting to the matrilin-2 expressed by transfected cells (Fig. 5C). The specificity of the antiserum was assessed by comparison of media from 293-EBNA cells before and after transfection with the recombinant plasmid pCEP-Mtr2, encoding the full-length mouse matrilin-2 (Fig. 5A). The transfected cells secreted into the culture medium matrilin-2, which was detected by the antiserum as a group of antigenic bands in nonreducing SDS-PAGE with apparent Mr values ranging from 70,000 to 500,000. On the basis of the calculated Mr = 104,300 for the nonmodified matrilin-2 monomer, faster migrating bands must represent degradation products, and the slower ones may correspond to oligomeric forms. We can conclude that the secretory signal peptide of matrilin-2 was functionally active in 293-EBNA cells and that matrilin-2 can form oligomers stable enough to resist denaturing electrophoresis if the sample is not reduced. The medium from nontransfected 293-EBNA cells did not show any reactivity with the antiserum, demonstrating the specificity of this reagent.


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 5.   SDS-PAGE analysis of recombinant matrilin-2 before (A) and after (B) purification and of matrilin-2 in cell media and tissue extracts (C). A, media from 293-EBNA cells either transfected with pCEP-Mtr2 (lane 1) or without transfection (lane 2) were applied to SDS-PAGE without prior reduction. Matrilin-2 was detected by immunoblotting using an affinity-purified antiserum to matrilin-2. B, purified recombinant matrilin-2 was submitted to SDS-PAGE as in A without (-SH) or after (+SH) sample reduction, and the gel was stained with Coomassie Brilliant Blue. C, media from 293-EBNA cells transfected with pCEP-Mtr2 and a variety of cell lines as well as extracts from mouse skin and uterus were submitted to SDS-PAGE and immunoblotting as in A. Nonreduced samples were run on 4-15% polyacrylamide gels; reduced ones were analyzed on 10% polyacrylamide gels. fn, the position of fibronectin.

The relative amounts of the different forms of matrilin-2, resolved by electrophoresis, differ somewhat between the crude media of transfected cells and preparations chromatographically purified from this source (Fig. 5B). The reason for this difference is that during purification we removed degradation fragments and enriched slightly for the oligomeric forms. Reduction of the purified material yielded several closely spaced bands with apparent Mr values between 100,000 and 130,000. The size heterogeneity was even more apparent when nonreduced samples from media of a variety of cell lines as well as extracts of skin and uterus were analyzed by immunoblotting (Fig. 5C). All the cell lines tested secreted detectable amounts of matrilin-2, with the exception of the epithelial cell line IEC6. Because the IEC6 cells showed production of matrilin-2 mRNA, we need to assume that the mRNA is translated and/or the protein is secreted with a very low efficiency in that cell line. While the 293-EBNA cells that had been transfected with pCEP-Mtr2 produced four groups of bands that may represent monomers, dimers, trimers, and tetramers, most cell lines secreted mainly the smallest and largest components. Extracts of skin and uterus showed, in addition, a relative abundance of the potential trimers. The analysis was, however, complicated by the presence of discrete differences in the electrophoretic mobility of corresponding matrilin-2 bands between sources (Fig. 5C).

Analysis of Posttranslational Modifications in Matrilin-2-- While the presence of matrilin-2 oligomers of variable sizes can be explained by source-specific differences in assembly, the multiple size of monomers indicated that, in addition to this, posttranslational processing occurs, possibly in a tissue-specific manner. A set of experiments was designed to explore this possibility (Fig. 6). The most obvious cause for the heterogeneity would be proteolysis after secretion into the culture medium. Samples of medium were, therefore, harvested at different times after medium change, frozen, and analyzed by immunoblotting (Fig. 6A). The band patterns of matrilin-2 obtained from medium kept with the cells at 37 °C for different periods of time show great similarities. With the exception of degradation fragments, which are clearly smaller than monomers, all components could be observed already after 8 h, indicating that proteolysis in the medium or in the intercellular compartment of tissues is not the major cause of heterogeneity. The size differences could also be due to a variable substitution with glycosaminoglycans or oligosaccharides. To test for the presence of sulfated glycosaminoglycans, cultures of wild type and matrilin-2-transfected 293-EBNA cells were, therefore, labeled with [35S]sulfate, and the media were analyzed by SDS-PAGE followed by autofluorography (Fig. 6B). The labeling patterns seen with the two sets of cultures showed considerable similarities, and, most importantly, only minor amounts of label were detected in the position of matrilin-2 monomers, which were shown by parallel immunoblotting to be the major matrilin-2 species in the sample. Further, media from matrilin-2-transfected 293-EBNA cells were digested with the glycosaminoglycan-degrading enzymes chondroitinase ABC and heparitinase under standard conditions (Fig. 6C). The treated samples appeared unchanged when compared with untreated samples by immunoblotting for matrilin-2, which provided further evidence against a substitution with chondroitin/dermatan sulfate or heparan sulfate. The potential presence of N-linked oligosaccharides was analyzed in two experiments. In one approach, parallel cultures of matrilin-2-transfected 293-EBNA cells were treated or not treated with the inhibitor tunicamycin (Fig. 6, D and E). SDS-PAGE and immunoblot analysis of the media showed small but significant increases in the mobility of matrilin-2 bands, which were, because of the better resolution, more easily seen by electrophoresis after reduction (Fig. 6E). Treatment of purified matrilin-2 with N-glycosidase F gave similarly small, but clearly detectable, decreases in the apparent Mr as visualized by SDS-PAGE (Fig. 6F). Taken together, these results show that the recombinant matrilin-2 carries N-linked oligosaccharides, but the extent of this glycosylation is not sufficient to explain the heterogeneity observed both with recombinantly expressed matrilin-2 and with matrilin-2 derived from cell lines and tissues. Neither tunicamycin treatment nor digestion with N-glycosidase F decreased the heterogeneity of recombinant matrilin-2, a finding that points to another underlying cause.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 6.   Analysis of the heterogeneity of matrilin-2 by SDS-PAGE. A, accumulation of matrilin-2 in cell culture media. Samples were harvested from 293-EBNA cells transfected with pCEP-Mtr2 8, 24, and 48 h after medium change. Aliquots were applied to a 4-15% SDS-PAGE without prior reduction. Matrilin-2 was detected by immunoblotting using an affinity-purified antiserum. B, electrophoretic analysis of sulfate-labeled products secreted into the medium. 293-EBNA cells either transfected with pCEP-Mtr2 (lane 2) or without transfection (lane 3) were cultured in the presence of 50 µCi/ml [35S]sulfate for 48 h, and aliquots of the media were applied to a 4-15% SDS-PAGE without prior reduction. The radioactive macromolecules were detected by autofluorography. In parallel, a lane containing medium from the transfected cells was blotted and reacted with the matrilin-2 antiserum (lane 1). C, media from matrilin-2-transfected cells were digested with heparitinase (lane 1), not digested (lane 2), or digested with chondroitinase ABC (lane 3). The samples were applied to gel electrophoresis and developed by immunoblotting as in A. D and E, 293-EBNA cells transfected with pCEP-Mtr2 were cultured in the presence (+) or absence (-) of 0.5 mg/ml tunicamycin, and aliquots of media were applied to either 4-15% SDS-PAGE without prior reduction (D) or 6% SDS-PAGE after reduction (E). Matrilin-2 was detected in the samples by immunoblot analysis. F, purified recombinant matrilin-2 was digested (+) or not digested (-) with N-glycosidase F, applied to a 4-15% SDS-PAGE, and stained with silver nitrate.

Electron Microscopy Reveals That Matrilin-2 Occurs as a Mixture of Monomers and Oligomers-- Purified, recombinant matrilin-2 (Fig. 5B) was negatively stained with uranyl formate to produce high resolution images by electron microscopy. Fields of stained molecules showed particles of heterogenous size (Fig. 7, top), and close examination of single particles revealed that all species from monomers to tetramers were present in the sample. At high magnification it was seen that, irrespective of the number of subunits within a molecule, all subunits are joined at a single point (Fig. 7, bottom), which presumably represents the coiled-coil alpha -helix assembled from the C-terminal domains. In most cases, the subunit is seen as a looped structure with a more heavily stained hole in the middle and frequently, but not always, carrying most mass in the periphery. The average diameter of the loops was 8 nm. Occasionally particles were seen where the loop was opened into a flexible rod, better representing the tandem array of domains making up the subunits.


View larger version (156K):
[in this window]
[in a new window]
 
Fig. 7.   Negative stain electron microscopy of purified recombinant matrilin-2. An overview (top) and selected particles at higher magnification (bottom) show the heterogeneity in oligomerization and illustrate the presence of subunits in a looped (particles 1, 2, 4, and 6 from the left) or open (particles 3 and 5 from the left) conformation. The bar corresponds to 100 nm for the overview (top) and 25 nm for the enlarged single molecules (bottom).

The Protein Forms an Extracellular Filamentous Network in Cell Culture-- In order to study the extracellular assembly forms of matrilin-2, the pericellular matrix of cultured primary smooth muscle cells from rat aorta was analyzed in immunofluorescence microscopy with specific antibodies against matrilin-2 (Fig. 8). Matrilin-2 was detected in an extensive, branched fibrillar network. The network may be connected to the cell surface, but in experiments where the cells were permeabilized (Fig. 8B), and thereby better outlined through the staining of the intracellular pool of immunoreactive matrilin-2, it was clear that the fibrils were not limited to the cell surface but extended over and beyond cells.


View larger version (131K):
[in this window]
[in a new window]
 
Fig. 8.   Immunofluorescence microscopy of matrilin-2-containing assemblies in the pericellular matrix of cultured primary rat aorta smooth muscle cells. Confluent cell layers were fixed in 2% paraformaldehyde, and matrilin-2 was detected with affinity-purified antibodies without (A) and with (B) permeabilization with 10% Nonidet P-40. An extensive network of matrilin-2-containing filaments is seen extracellularly, and after permeabilization an intracellular precursor pool is also detected. Bar, 20 µm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The Matrilin-2 Gene Is Transcribed in Fibroblasts, Myocytes, and Epithelial Cells, but the Protein Is Transported to Connective Tissue Structures-- During our previous work, matrilin-2 mRNA was found in skin of the tail, calvaria, heart, uterus, and brain (4). From the wide distribution of the transcript, expression of the gene in cell types common to many organs was presumed. In situ hybridization and Northern blotting data represented here confirmed gene expression in connective tissue cells but extended the expression pattern to muscle and epithelial cells. Most of the expressor cell types are of mesodermal origin, but the epithelia of trachea, esophagus, and intestine, which showed strong in situ hybridization signals, develop from endoderm. Expression of the matrilin-2 gene in cells of various developmental lineages predicts a complex mechanism for regulation of gene expression.

In some cases, synthesis of the matrilin-2 mRNA was found in epithelial cells, but deposition of the protein was observed only in subepithelial connective tissue. It is likely that the matrilin-2 mRNA is translated in epithelial cells and that the protein is specifically transported to the subepithelial regions. It is known that some components of basement membranes are made by epithelial cells; others are contributions from the underlying connective tissue fibroblasts. Nidogen is exclusively made and the alpha 1 and alpha 2 chains of collagen IV are predominantly produced by dermal fibroblasts, but all three chains of laminin-1 can be expressed by keratinocytes, especially at the beginning of coculturing (20). In the case of matrilin-2, the possibility cannot be excluded that epithelial cells synthesize mRNA, but translation or protein transport is blocked. The absence of matrilin-2 from media of the IEC6 intestinal epithelial cell line (Fig. 5C) supports this alternative, but this cell line might also not be representative for the differentiation state of epithelial cells in vivo.

Matrilin-2 Displays an Unusual Extent of Structural Heterogeneity-- In preparations of recombinant matrilin-2, at least three bands of reduced monomers can be resolved by SDS-PAGE (Fig. 6E). The size differences observed between matrilin-2 from different sources appear too large to be explained by these three bands occurring in variable proportions. In studies using the recombinant matrilin-2, we have excluded extracellular proteolysis and substitution with glycosaminoglycans or N-linked oligosaccharides as the major source of heterogeneity. Since the recombinant matrilin-2 is derived from cloned cDNA, alternative splicing may also be excluded. Remaining possibilities are unconventional forms of substitution and/or processing by intracellular or cell surface-bound proteases during biosynthesis and secretion. Further studies will be needed to evaluate these alternatives and to determine if the processing has functional consequences.

SDS-PAGE revealed also a second level of heterogeneity, with bands corresponding to various oligomeric species being present in recombinant matrilin-2 (Fig. 5). This cannot be explained by imperfect assembly due to overexpression in the transfected 293-EBNA cells, since similarly variable oligomerization is seen in tissue extracts and in media from a variety of cell lines (Fig. 5C). Different assembly forms representing all species from monomers to tetramers are seen in electron microscopy of samples purified under nondenaturing conditions (Fig. 7). This proves that the occurrence of multiple bands in SDS-PAGE is not due to incomplete closure of interchain disulfide bridges followed by dissociation of the coiled-coil upon treatment with SDS, but either that coiled-coil alpha -helices with varying numbers of protein strands are formed or that matrilin-2 subunits are specifically proteolytically cleaved at a site close to the coiled-coil region before or around secretion. Pan and Beck (6) recently investigated the oligomerization of a synthetic peptide corresponding to the coiled-coil domain of matrilin-2. By means of chemical cross-linking, they found that a trimer was the preferred species, but even at high cross-linking reagent concentrations, at which a corresponding matrilin-1-related peptide exclusively shows a single band corresponding to a trimeric state (21), the matrilin-2 peptide showed nearly equal amounts of material running in the position of monomers, dimers, and trimers (6). Under these conditions, higher molecular mass bands, although of lower concentrations, which can be interpreted to represent tetramers and pentamers, were also found. The multiplicity of oligomers could not be abolished by increasing the ionic strength as it was found for the matrilin-1 peptide (21). Although these authors argue that the monomeric and dimeric states observed upon SDS-PAGE might be due to the limitations of the cross-linking approach, they could not rule out that indeed different oligomerization states for the matrilin-2 related peptide are possible. Studies of matrilin-1 derived from tissue sources show that homooligomerization of the naturally occurring protein leads to the formation of trimers as the single predominant species (18). Recent work has, however, demonstrated restrictions in the stringency of coiled-coil formation among matrilins in showing that a single point mutation in the coiled-coil domain of matrilin-1 may cause it to form tetramers instead of trimers (22) and that matrilin-1 occurs in vivo not only as a homotrimer but also in a heterotetramer together with matrilin-3 subunits (23). In the case of matrilin-2, it could be that this lack of stringency leads to the protein occurring in vivo as a mixed set of monomers and oligomers. This heterogeneity may have functional consequences, since ligand binding sites will occur in variable copy number within a single molecule, and differences in oligomerization state may, because of cooperativity, lead to differences in affinity for macromolecular ligands that may bind to more than one subunit within a single matrilin-2 molecule. The possibility cannot be excluded that the oligomers detected by immunoblot are heterooligomers formed between matrilin-2 and another matrilin. A candidate would be matrilin-4, which is expressed outside cartilage as shown by Northern blots that give signals in lung, liver, brain, sternum, kidney, and heart (5).

Evidence for Self-interaction of vWFA Domains of Matrilin-2 and Its Potential Role in Fibrillar Network Formation in Cell Culture-- In electron microscopy using negative stain, the matrilin-2 subunits are most often seen as loop structures with a diameter of 8 nm, but in a smaller fraction of the particles they are seen to open into a flexible rod (Fig. 7). Based on x-ray crystallographic data, we may assume a diameter of 3.6 nm for vWFA domains and 2.1 nm for EGF-like domains. In a tandem array, the two A domains together with the 10 EGF-like domains would have a length of about 28 nm. A circle with a diameter of 8 nm has a circumference of 25 nm, and the measurements are, therefore, compatible with a model of the matrilin-2 subunit where a loop is formed through interactions between the two A domains. In earlier studies of matrilin-1, we similarly observed a compact structure of the subunits (18). Domain interactions within the subunit had to be assumed to explain why the length determined from electron micrographs was considerably smaller than that expected from the dimensions of the domains in tandem array. Since the A-domains in matrilin-1 are connected by a single EGF-like domain, substructures within the subunit could not be resolved, while in the matrilin-2 subunit, where the A-domains are connected by 10 EGF-like domains, a loop around a heavily stained hole could be seen. For sterical reasons, it is most likely that the loop is formed by the EGF-like domains, which are held together through an interaction between the two A-domains. Indeed, structures indicating self-interactions between Adomains have been observed by electron microscopy of von Willebrand factor (24) and of the N-terminal globule of the alpha 3 chain of type VI collagen (25). Further, by x-ray crystallography of von Willebrand factor A1-domain a contact surface was detected between A1-domain pairs, suggesting a hypothetical mechanism for the regulation of protein assembly and heterologous ligand binding mediated by homophilic interactions of type A-domains (26). vWFA domains in those proteins have also been shown to be involved in other interactions (25, 27).

By immunofluorescence microscopy of the matrix formed by cultured smooth muscle cells (Fig. 8), we could show that matrilin-2 molecules assemble into an extracellular fibrillar network, where each fibril may have a length of several cell diameters and often divides into smaller branches. In similar studies, matrilin-1 was found in chondrocyte cultures in close association with collagen II fibers (28), and a filamentous network, independent of collagen fibers, was also observed when matrilin-1 was overexpressed using a retroviral system (29). Matrilin-1 constructs, in which the vWFA1 domain had been deleted, assembled into trimers but could not form filamentous structures, thereby implicating the vWFA1 domain as being involved in the polymerization reaction leading to fibril formation. In analogy, it is likely that the vWFA domains of matrilin-2 may interact with each other and that filaments may be formed by this interaction. We do not know at present the exact molecular composition of the matrilin-2-positive extracellular filaments, but we are pursuing the study of such interactions of matrilin-2 with itself and with other extracellular macromolecules that may form the basis for fibril formation.

    ACKNOWLEDGEMENTS

We are indebted to Drs. G. K. Owens, J. H. Kimura, L. Sorokin, R. Hallmann, N. E. Fusenig, F. Michaelsen, and J. Karolat for providing the cell lines and to L. Módis, K. Addicks, and K. Beck for valuable discussion. We also thank I. Fekete for technical assistance and A. Borka and M. Tóth for artwork.

    FOOTNOTES

* This work was supported by joint grants from the Volkswagen-Stiftung (I/71 654) and the Bilateral German-Hungarian Cooperation Program (D-10/96/WTZ), Hungarian National Scientific Research Foundation Grants OTKA T023803 and T029157, Deutsche Forschungsgemeinschaft Grant Kr 558/10-3, and a grant from the Köln Fortune program of the Medical Faculty of the University of Cologne.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Institute of Biochemistry, Biological Research Center, Hungarian Academy of Sciences, P.O. Box 521, H-6701 Szeged, Hungary. Tel.: 36-62-432-232; Fax: 36-62-433-506; E-mail: matrix{at}nucleus.szbk.u-szeged.hu.

    ABBREVIATIONS

The abbreviations used are: vWFA, von Willebrand factor type A-like; EGF, epidermal growth factor; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
  1. Deák, F., Wagener, R., Kiss, I., and Paulsson, M. (1999) Matrix Biol. 18, in press
  2. Wagener, R., Kobbe, B., and Paulsson, M. (1997) FEBS Lett. 413, 129-134[CrossRef][Medline] [Order article via Infotrieve]
  3. Belluoccio, D., and Trueb, B. (1997) FEBS Lett. 415, 212-216[CrossRef][Medline] [Order article via Infotrieve]
  4. Deák, F., Piecha, D., Bachrati, C., Paulsson, M., and Kiss, I. (1997) J. Biol. Chem. 272, 9268-9274[Abstract/Free Full Text]
  5. Wagener, R., Kobbe, B., and Paulsson, M. (1998) FEBS Lett. 436, 123-127[CrossRef][Medline] [Order article via Infotrieve]
  6. Pan, O. H., and Beck, K. (1998) J. Biol. Chem. 273, 14205-14209[Abstract/Free Full Text]
  7. Yaffe, D., and Saxel, O. (1977) Nature 270, 725-727[Medline] [Order article via Infotrieve]
  8. Blank, R. S., Swartz, E. A., Thompson, M. M., Olson, E. N., and Owens, G. K. (1995) Circ. Res. 76, 742-749[Abstract/Free Full Text]
  9. Fusenig, N. E., Amer, S. M., Boukamp, P., and Worst, P. K. (1978) Bull. Cancer (Paris) 65, 271-280[Medline] [Order article via Infotrieve]
  10. Pfeiffer, S. E., and Wechsler, W. (1972) Proc. Natl. Acad. Sci. U. S. A. 69, 2885-2889[Abstract]
  11. Mukhopadhyay, K., Lefebre, V., Zhou, G., Garofalo, S., Kimura, J. H., and de Crombrugghe, B. (1995) J. Biol. Chem. 270, 27711-27719[Abstract/Free Full Text]
  12. Sorokin, L. M., Gopfert, T., Hallmann, R., and Deutzmann, R. (1994) Eur. J. Biochem. 223, 603-610[Abstract]
  13. O'Connell, K. A., and Edidin, M. (1990) J. Immunol. 144, 521-525[Abstract/Free Full Text]
  14. Akita, M., Murata, E., Schroter-Kermani, C., and Merker, H. J. (1993) Pathobiology 61, 98-103[Medline] [Order article via Infotrieve]
  15. Hofstetter, W., Wetterwald, A., Cecchini, M. C., Felix, R., Fleisch, H., and Mueller, C. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9637-9641[Abstract]
  16. Kohfeldt, E., Maurer, P., Vannahme, C., and Timpl, R. (1997) FEBS Lett. 414, 557-561[CrossRef][Medline] [Order article via Infotrieve]
  17. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  18. Hauser, N., and Paulsson, M. (1994) J. Biol. Chem. 269, 25747-25753[Abstract/Free Full Text]
  19. Engel, J., and Furthmayr, H. (1987) Methods Enzymol. 145, 3-78[Medline] [Order article via Infotrieve]
  20. Smola, H., Stark, H. J., Thiekotter, G., Mirancea, N., Krieg, T., and Fusenig, N. E. (1998) Exp. Cell Res. 239, 399-410[CrossRef][Medline] [Order article via Infotrieve]
  21. Beck, K., Gambee, J. E., Bohan, C. A., and Bachinger, H. P. (1996) J. Mol. Biol. 256, 909-923[CrossRef][Medline] [Order article via Infotrieve]
  22. Beck, K., Gambee, J. E., Kamawal, A., and Bachinger, H. P. (1997) EMBO J. 16, 3767-3777[Abstract/Free Full Text]
  23. Wu, J. J., and Eyre, D. R. (1998) J. Biol. Chem. 273, 17433-17438[Abstract/Free Full Text]
  24. Fowler, W. E., and Fretto, L. J. (1989) in Coagulation and Bleeding Disorders (Zimmermann, T. S., and Ruggeri, Z. M., eds), pp. 181-194, Dekker, New York
  25. Specks, U., Mayer, U., Nischt, R., Spissinger, T., Mann, K., Timpl, R., Engel, J., and Chu, M.-L. (1992) EMBO J. 11, 4281-4290[Abstract]
  26. Celikel, R., Varughese, K. I., Madhusudan, A., Yoshioka, A., Ware, J., and Ruggeri, Z. M. (1998) Nat. Struct. Biol. 5, 189-194[Medline] [Order article via Infotrieve]
  27. Sadler, J. E. (1991) J. Biol. Chem. 266, 22777-22780[Free Full Text]
  28. Winterbottom, N., Tondravi, M. M., Harrington, T. L., Klier, F. G., Vertel, B. M., and Goetinck, P. F. (1992) Dev. Dyn. 193, 266-276[Medline] [Order article via Infotrieve]
  29. Chen, Q., Johnson, D. M, Haudenschild, D. R., Tondravi, M. M., and Goetinck, P. F. (1995) Mol. Biol. Cell 6, 1743-1753[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.